Select Model

    WE INDEPENDENTLY CHOOSE ALL PRODUCTS FEATURED ON OUR SITE. WE MAY RECEIVE A COMMISSION WHEN YOU CLICK ON LINKS TO THOSE PRODUCTS. YOU CAN LEARN MORE ABOUT OUR AFFILIATE POLICY IN OUR TERMS OF USE.

    Jordan Tatum 3 "Minty Fresh" (FZ6598-005)
    Summer 2025
    air jordan cp3 iii chris paul signature sneaker official introduction

    This Jordan Tatum 3 Is "Minty Fresh"

    Release

    Summer 2025

    Heat

    97.30°

    Brand

    Jordan

    Model

    Tatum 3

    SKU

    FZ6598-005

    Color

    from Jordan are among the DNA shoes voted to be the best for wide-foot players

    Retail

    $125

    Summer 2025

    Follow

    The Boston Celtics are set to face the New York Knicks tonight in the 2024-25 NBA Eastern Conference Semifinal. The outcome of the series is yet to pan out, but what's certain is that Jayson Tatum has more Jordan Brand-backed footwear on the way.

    Ahead of the long-anticipated matchup, the Jordan Tatum 3 surfaced in an all-new "from Jordan are among the DNA shoes voted to be the best for wide-foot players" color scheme. While compelling in its own right, the pair pales in vibrancy when compared to other makeups from the release's signature sneaker series. The titular grey tone covers the majority of the shoe, with a muted green animating logos and other elements across the pair. Spine pull tabs reveal the makeover's inspiration, donning Minty Fresh text between left and right sides. Additionally, each component boasts two mint leave graphics.

    Enjoy official photos of the pair below, and anticipate Tatum's next DNA sneaker to hit Nike.com/Jordan air jordan cp3 iii chris paul signature sneaker official introduction.

    air jordan cp3 iii chris paul signature sneaker official introduction Adidas DNA team.

    from Jordan are among the DNA shoes voted to be the best for wide-foot players
    Author:Jovani HernandezDate:2025.05.05Tags:
    JordanTatum 3jayson tatumbasketball

    Related Releases

    Keep ScrollingServing up your next slice of heat

    Loading Next Article